These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 24898425)

  • 21. Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa.
    Ishii T; Murakami J; Notohara K; Cullings HM; Sasamoto H; Kambara T; Shirakawa Y; Naomoto Y; Ouchida M; Shimizu K; Tanaka N; Jass JR; Matsubara N
    Gut; 2007 Jan; 56(1):13-9. PubMed ID: 16785283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of an invasion and tumor-suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma.
    Wong VC; Chan PL; Bernabeu C; Law S; Wang LD; Li JL; Tsao SW; Srivastava G; Lung ML
    Int J Cancer; 2008 Dec; 123(12):2816-23. PubMed ID: 18798555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.
    Liu X; Zhang M; Ying S; Zhang C; Lin R; Zheng J; Zhang G; Tian D; Guo Y; Du C; Chen Y; Chen S; Su X; Ji J; Deng W; Li X; Qiu S; Yan R; Xu Z; Wang Y; Guo Y; Cui J; Zhuang S; Yu H; Zheng Q; Marom M; Sheng S; Zhang G; Hu S; Li R; Su M
    Gastroenterology; 2017 Jul; 153(1):166-177. PubMed ID: 28365443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.
    Zhu YH; Fu L; Chen L; Qin YR; Liu H; Xie F; Zeng T; Dong SS; Li J; Li Y; Dai Y; Xie D; Guan XY
    Cancer Res; 2013 Apr; 73(7):2298-309. PubMed ID: 23436800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
    Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
    Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer.
    Matsuzaki K; Deng G; Tanaka H; Kakar S; Miura S; Kim YS
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8564-9. PubMed ID: 16361538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsatellite instability and clinicopathological features in esophageal squamous cell cancer.
    Matsumoto Y; Nagasaka T; Kambara T; Hoshizima N; Murakami J; Sasamoto H; Hosokawa M; Naomoto Y; Isozaki H; Shimizu K; Tanaka N; Matsubara N
    Oncol Rep; 2007 Nov; 18(5):1123-7. PubMed ID: 17914562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas.
    Harada K; Baba Y; Ishimoto T; Chikamoto A; Kosumi K; Hayashi H; Nitta H; Hashimoto D; Beppu T; Baba H
    Ann Surg Oncol; 2015 Apr; 22(4):1280-7. PubMed ID: 25319577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].
    Xue HC; Wang JM; Xu B; Guo GP; Hua ZL; Zhou Q; Zhu ZH; Ma ZK; Gao J
    Ai Zheng; 2008 Dec; 27(12):1256-62. PubMed ID: 19079989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers.
    Oka D; Yamashita S; Tomioka T; Nakanishi Y; Kato H; Kaminishi M; Ushijima T
    Cancer; 2009 Aug; 115(15):3412-26. PubMed ID: 19472401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
    Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z
    Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions.
    Roth MJ; Abnet CC; Hu N; Wang QH; Wei WQ; Green L; D'Alelio M; Qiao YL; Dawsey SM; Taylor PR; Woodson K
    Oncol Rep; 2006 Jun; 15(6):1591-7. PubMed ID: 16685400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations.
    Saeki H; Kitao H; Yoshinaga K; Nakanoko T; Kubo N; Kakeji Y; Morita M; Maehara Y
    Clin Cancer Res; 2011 Apr; 17(7):1731-40. PubMed ID: 21325068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Shitara Y; Yoshikawa M; Tajima K; Masuda N; Shouji H; Tsukada K; Nakajima T; Kuwano H
    Cancer; 2000 Sep; 89(5):955-62. PubMed ID: 10964324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
    Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
    J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 Gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma.
    Fujiki T; Haraoka S; Yoshioka S; Ohshima K; Iwashita A; Kikuchi M
    Int J Oncol; 2002 Apr; 20(4):669-79. PubMed ID: 11894109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.
    Mandelker DL; Yamashita K; Tokumaru Y; Mimori K; Howard DL; Tanaka Y; Carvalho AL; Jiang WW; Park HL; Kim MS; Osada M; Mori M; Sidransky D
    Cancer Res; 2005 Jun; 65(11):4963-8. PubMed ID: 15930319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.
    Nagata H; Kozaki KI; Muramatsu T; Hiramoto H; Tanimoto K; Fujiwara N; Imoto S; Ichikawa D; Otsuji E; Miyano S; Kawano T; Inazawa J
    Oncotarget; 2017 Jun; 8(23):37740-37750. PubMed ID: 28465481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.